Redhill Biopharma
RDHL
#11120
Rank
NZ$5.18 M
Marketcap
NZ$0.85
Share price
-0.27%
Change (1 day)
-77.11%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: NZ$5.18 Million

As of October 2026 Redhill Biopharma has a market cap of NZ$5.18 Million. This makes Redhill Biopharma the world's 11120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.18 M-48.23%
2025NZ$10.02 M-36.11%
2024NZ$15.68 M-65.46%
2023NZ$45.42 M125.37%
2022NZ$20.15 M-89.82%
2021NZ$0.19 B-53.11%
2020NZ$0.42 B32.79%
2019NZ$0.31 B35.43%
2018NZ$0.23 B52.46%
2017NZ$0.15 B-40.23%
2016NZ$0.25 B7.68%
2015NZ$0.23 B59.99%
2014NZ$0.14 B61.69%
2013NZ$92.47 M

End of Day market cap according to different sources

On Sep 30th, 2026 the market cap of Redhill Biopharma was reported to be:

NZ$5.18 Million
by Nasdaq info icon info icon
NZ$5.18 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
NZ$175.62 B 3,384,556.54%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$637.31 B 12,282,333.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$171.50 B 3,305,155.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$82.10 B 1,582,212.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
NZ$2.87 B 55,230.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel